Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

about

Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction.

P2860

Q38855424-D4394D8F-6CCB-4243-B283-D896F2F04D9B

P2860

Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

Item

http://www.wikidata.org/entity/Q38766202

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

@en

type

Item

label

Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

@en

prefLabel

Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

@en

P1476

Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

@en

P2093

Amany K Hassan

http://www.w3.org/2001/XMLSchema#string

Ashley E Woodruff

http://www.w3.org/2001/XMLSchema#string

Ashley M Kelley

http://www.w3.org/2001/XMLSchema#string

Carolyn A Hempel

http://www.w3.org/2001/XMLSchema#string

Christine A Echtenkamp

http://www.w3.org/2001/XMLSchema#string

William J Loeffler

http://www.w3.org/2001/XMLSchema#string

P2860

Patterns of weight change preceding hospitalization for heart failure

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.

P304

437-445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028016637385

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26956954

http://www.w3.org/2001/XMLSchema#string

Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

about

P2860

P2860

Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698